NEJM - "Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults"

"Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults"

"CONCLUSIONS

The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older. Vaccine efficacy in adults who were 70 years of age or older was similar to that in the other two age groups. (Funded by GlaxoSmithKline Biologicals; ZOE-50 ClinicalTrials.gov number, NCT01165177.)"  

http://www.nejm.org/doi/full/10.1056/NEJMoa1501184?query=featured_home